Irene Tennant, the head of clinical development and regulatory affairs at AGT, speaks about her role in the development of gene and cell therapies to treat human diseases. She works to progress potential therapies into the clinic, and ultimately to the bedsides of thousands of people.
In this video, Jeff Galvin and Irene Tennant have a conversation about their work at American Gene Technologies (AGT), a gene therapy company, built to cure diseases that were previously thought of as incurable. The mission statement of the company is to “reduce human suffering and death from serious human diseases.”
In this video, Jeff Galvin explains how American Gene Technologies (AGT) uses genetic modifications in the body to change how viral diseases interact with the immune system.
Gene therapy is accelerating at an incredibly fast and impressive rate. AGT is at the forefront of this progress, fuelling the gene therapy market.
This video explains the ins and outs of cell therapy. Dr. C. David Pauza, Chief Science Officer of American Gene Technologies, explains how one tiny dot on a cell, a virus, can kill a person, but this dot can be changed from the infectious root of disease into curative genetic medicine.